Biomarkers Accurately Inform Treatment Decisions in Localized Prostate Cancer.

Journal Article (Journal Article)

Biomarkers are now ubiquitous in prostate cancer care. In addition to longstanding use of prostate-specific antigen, we now have secondary serum-, urine-, and tissue-based markers that help in optimizing patient care and patient compliance with therapeutic recommendations. The ship has sailed: these markers are useful and are here to stay.

Full Text

Duke Authors

Cited Authors

  • Moul, JW

Published Date

  • May 2022

Published In

Volume / Issue

  • 8 / 3

Start / End Page

  • 641 - 642

PubMed ID

  • 35644849

Electronic International Standard Serial Number (EISSN)

  • 2405-4569

Digital Object Identifier (DOI)

  • 10.1016/j.euf.2022.05.001


  • eng

Conference Location

  • Netherlands